Korita and co-workers [8] and our research group [9] recently reported that HCC cells produce drug resistance via MRP2 overexpression, which comprises the major problem associated with the available chemotherapeutic agents in 30–80% of cancer patients [10,11]. Here, ABCC2 is linked to cancer.